Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-19 Sale |
2025-02-21 5:10 pm |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
4,326 | $4.413 | $19,091 | 220,119 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 5:00 pm |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
2,500 | $8.1965 | $20,491 | 239,350 (Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 5:33 pm |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
2,500 | $7.8227 | $19,557 | 241,850 (Direct) |
View |
| 2024-10-10 Sale |
2024-10-15 1:45 pm |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $8.0991 | $40,496 | 244,350 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-11 5:17 pm |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $10.65 | $53,274 | 249,350 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-13 6:34 pm |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $11.53 | $57,635 | 254,350 (Direct) |
View |
| 2024-07-10 Sale |
2024-07-12 4:55 pm |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
55,000 | $16.79 | $923,388 | 259,350 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-12 5:00 pm |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $17.65 | $88,264 | 314,350 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-14 4:04 pm |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $13.22 | $66,093 | 319,350 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Option Award |
2025-04-01 7:58 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
2,128 | $2.61 | 222,247 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-10 4:55 pm |
N/A 2035-01-06 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
311,250 | $0 | 431,945 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 5:00 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
2,500 | $2.33 | 239,350 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 5:00 pm |
N/A 2031-02-15 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
2,500 | $0 | 239,350 (Direct) |
View |
| 2024-11-11 Exercise |
2024-11-13 5:33 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
2,500 | $2.33 | 241,850 (Direct) |
View |
| 2024-11-11 Exercise |
2024-11-13 5:33 pm |
N/A 2031-02-15 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
2,500 | $0 | 241,850 (Direct) |
View |
| 2024-10-10 Exercise |
2024-10-15 1:45 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $2.33 | 244,350 (Direct) |
View |
| 2024-10-10 Exercise |
2024-10-15 1:45 pm |
N/A 2031-02-15 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $0 | 244,350 (Direct) |
View |
| 2024-09-10 Exercise |
2024-09-11 5:17 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $2.33 | 249,350 (Direct) |
View |
| 2024-09-10 Exercise |
2024-09-11 5:17 pm |
N/A 2031-02-15 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $0 | 249,350 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-13 6:34 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $2.33 | 254,350 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-13 6:34 pm |
N/A 2031-02-15 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $0 | 254,350 (Direct) |
View |
| 2024-07-10 Exercise |
2024-07-12 4:55 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $2.33 | 259,350 (Direct) |
View |
| 2024-07-10 Exercise |
2024-07-12 4:55 pm |
N/A 2031-02-15 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $0 | 259,350 (Direct) |
View |
| 2024-06-10 Exercise |
2024-06-12 5:00 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $2.33 | 314,350 (Direct) |
View |
| 2024-06-10 Exercise |
2024-06-12 5:00 pm |
N/A 2031-02-15 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $0 | 314,350 (Direct) |
View |
| 2024-05-13 Exercise |
2024-05-14 4:04 pm |
N/A 2031-02-15 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
5,000 | $2.33 | 319,350 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 6:52 pm |
N/A 2034-01-04 |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
306,250 | $0 | 433,195 (Direct) |
View |
Ownership |
2023-11-02 9:42 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
0 | $0 | 906,222 (Direct) |
View |